 Current status mold immunotherapy evidence molds IgE-mediated upper respiratory tract disorders immunotherapy efficacious select group environmental sampling studies small numbers molds majority mold load various diverse locations Cladosporium Basidiospores Aspergillus Alternaria-Penicillin families Basidiospores studies difficulties identification absolute mold level important factor IgE formation induction upper respiratory tract symptoms uncertain majority studies assumption absolute level mold environment important factor development symptoms strong evidence major problem majority studies lack standardization extracts false negatives skin testing variable data population evaluations prevalence mold ability IgE production symptoms current trials efficacy mold immunotherapy standardized Cladosporium extract results available mold extracts available United immunotherapy skin testing extracts variable potency prone high false negative rates serve poor skin reagents immunotherapy reagents standardized mold reagents Cladosporium data meaningful way